MYR1 knockouts display an expected reduction in virulence in vivo, but this phenotype is lost in pooled knockout CRISPR screens, suggesting MYR1-dependent effectors may exert paracrine effects at the site of infection [22]. The gene discussed is MYO1B; the disease is infection.